{"id":"W3170209696","doi":"10.1136/ijgc-2020-002240","title":"Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3","year":2021,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"National Cancer Institute; Takeda Oncology; Janssen Research and Development; EMD Serono; Genentech; Shire; Astellas Pharma; Eisai; University College London; Syndax Pharmaceuticals; Mersana Therapeutics; National Institute for Health and Care Research; Clovis Oncology; U.S. Department of Defense; National Comprehensive Cancer Network; Ovarian Cancer Research Fund; Gateway Foundation; Les Laboratories Pierre Fabre; AstraZeneca; Novocure; Amgen; American Association for Cancer Research; National Ovarian Cancer Coalition; National Institutes of Health; Regeneron Pharmaceuticals; Ipsen; Array BioPharma; Ludwig Institute for Cancer Research; Memorial Sloan-Kettering Cancer Center; PharmaMar; Yale University; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb; NuCana; Incyte; Pfizer; Ovarian Cancer Research Fund Alliance; Stand Up To Cancer; Entertainment Industry Foundation","keywords":"Medicine; Internal medicine; Progression-free survival; Population; Oncology; Placebo; Randomized controlled trial; Confidence interval; PARP inhibitor; Gastroenterology; Surgery; Chemotherapy; Poly ADP ribose polymerase; Pathology; Polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003081869,0.0009643789,0.002564865,0.0003756557,0.0003578566,0.001159278,0.0009939494,0.001195879,0.004205408],"category_scores_gemma":[0.002171523,0.0004502673,0.002289281,0.0005548817,0.001117166,0.001222003,0.0004234252,0.004639375,0.0006070923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008122312,"about_ca_system_score_gemma":0.001375171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001218052,"about_ca_topic_score_gemma":0.003529046,"domain_scores_codex":[0.9988673,0.000667225,0.00005148636,0.0001399982,0.00009377074,0.000180428],"domain_scores_gemma":[0.9983813,0.0005791987,0.0003661282,0.0001865093,0.00005615754,0.0004308211],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9506059,0.003712978,0.002352082,0.0002535287,0.00200957,0.00003239026,0.00005460426,0.0006720719,0.002711506,0.0001417036,0.0008975986,0.03655609],"study_design_scores_gemma":[0.8350248,0.1443206,0.01344531,0.00004537967,0.002122953,0.0001260477,0.00005079986,0.001605712,0.001232861,0.0003724813,0.001607573,0.00004553244],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912884,0.005046803,0.0004209756,0.0004824891,0.0001353479,0.0003793115,0.000777074,0.0001186481,0.001350943],"genre_scores_gemma":[0.9938148,0.001595318,0.0008484778,0.0005845306,0.0001986431,0.0004558921,0.001103872,0.00004249923,0.001355876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004205408,"threshold_uncertainty_score":0.01629871,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03522870606063486,"score_gpt":0.3851610700811711,"score_spread":0.3499323640205362,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}